Beware of False “Cures” for Autism
What you need to know
Unapproved and Potentially Harmful Products
Autism Spectrum Disorder (ASD) affects about 1 in 68 children, and while early behavioral therapies can help improve symptoms, there is no cure for autism. Unfortunately, some companies promote unproven products that falsely claim to treat or even cure ASD — and some can be dangerous.
What the FDA Wants You to Know
The FDA has acted against companies marketing unapproved and potentially harmful products that claim to treat autism. These include:
- Chelation Therapies (sprays, drops, baths): Meant to remove “toxins,” but can dangerously deplete essential minerals.
- Hyperbaric Oxygen Chambers: Only approved for specific medical uses — not autism.
- Detoxifying Clay Baths: Claim to “pull out toxins” through the skin — no evidence they help.
- MMS (chlorine dioxide), raw camel milk, essential oils, and others: Heavily marketed, not scientifically proven, and can pose real health risks.
FDA-Approved Treatments Exist — But Only for Specific Symptoms
There are two FDA-approved medications to manage irritability associated with autism:
- Risperidone (ages 5–16)
- Aripiprazole (ages 6–17)
These medications help with specific symptoms — not autism itself — and should only be used under medical supervision.
Real Help for ASD
- Early behavioral interventions can improve communication and daily living skills.
- Treatment should be tailored to the individual’s needs.
- Work with licensed healthcare professionals, not unregulated products.
Watch Out for These Red Flags
- “Quick fixes” or “miracle cures”
- Claims to treat a wide range of unrelated conditions
- Personal stories with no scientific backing
- Secret ingredients or “breakthrough science”
If it sounds too good to be true, it probably is.
If you have questions about therapies or treatments, talk to a doctor who specializes in autism. Trust science — not sales pitches.
FDA Targets Online Marketing of Unapproved Drugs
FDA Issues 14 Warning Letters Targeting Online Unapproved Drug Sales The U.S. Food and Drug Administration (FDA) has issued a coordinated series of warning letters targeting companies marketing unapproved drug products online, signaling an intensified enforcement...
FDA Approves First Treatment to Reduce Risk of Acute Pancreatitis
FDA Approves First Treatment Proven to Reduce Acute Pancreatitis Risk in Severe HypertriglyceridemiaAn important example of the distinction between surrogate endpoints and clinical outcomes in drug development The U.S. Food and Drug Administration (FDA) has approved...
Infant Formula Recalled after Reports of Botulism
Three Infants Hospitalized; Nationwide Recall Initiated Nara Organics has voluntarily recalled all lots of its powdered infant formula currently on the U.S. market following reports of three cases of infant botulism in infants who reportedly consumed the product. ...